Autologous blood predonation programme

Active Ingredient: Epoetin zeta

Indication for Epoetin zeta

Population group: only adults (18 years old or older)

Epoetin zeta is indicated in adults in a predonation programme to increase the yield of autologous blood. Treatment should only be given to patients with moderate anaemia (haemoglobin [Hb] concentration range between 10 to 13 g/dL [6.2 to 8.1 mmol/L], no iron deficiency) if blood saving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).

For this indication, competent medicine agencies globally authorize below treatments:

600 IU/kg once every 3 days

Route of admnistration

Intravenous

Defined daily dose

600 - 600 [iU] per kg of body weight

Dosage regimen

From 600 To 600 [iU] per kg of body weight once every 3 day(s)

Detailed description

Mildly anaemic patients (haematocrit of 33 to 39%) requiring predeposit of ≥4 units of blood should be treated with epoetin zeta 600 IU/kg intravenously, 2 times per week for 3 weeks prior to surgery. Epoetin zeta should be administered after the completion of the blood donation procedure.

Dosage considerations

Administer over at least one to five minutes, depending on the total dose. In haemodialysed patients, a bolus injection may be given during the dialysis session through a suitable venous port in the dialysis line. Alternatively, the injection can be given at the end of the dialysis session via the fistula needle tubing, followed by 10 mL of isotonic saline to rinse the tubing and ensure satisfactory injection of the product into the circulation.

Active ingredient

Epoetin zeta

Epoetin zeta is a recombinant human erythropoietin. Erythropoietin (EPO) is a glycoprotein hormone produced primarily by the kidney in response to hypoxia and is the key regulator of red blood cell (RBC) production. The 2 are indistinguishable on the basis of functional assays.

Read more about Epoetin zeta

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.